CRMD
CorMedix Inc.
-0.10 (-1.28%)7.72USD215K成交股數602M市值3.5本益比(近四季)1.3股價營收比+156.5%營收年增(近四季)2026-11-16下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 102M+157% | 127M+226% | 129M+1023% | 104M+12835% | 39.7M | 39.1M | 11.5M | 806K | – | – | – | – |
| 營業成本 | 14.5M | 12.0M | 11.1M | 7.6M | 1.9M | 1.5M | 635K | 510K | 819K | – | – | – |
| 毛利 | 77.1M+104% | 105M+180% | 107M+896% | 93.1M+31316% | 37.9M-4727% | 37.5M | 10.8M | 296K | −819K | – | – | – |
| 毛利率 | 75.7% | 82.5% | 83.4% | 89.3% | 95.3% | 95.9% | 94.0% | 36.8% | – | – | – | – |
| 研發費用 | 6.7M | 7.2M | 8.6M | 5.1M | 2.4M | 3.2M | 727K | 651K | 837K | 2.3M | 2.7M | 4.8M |
| 銷售管理費用 | 15.1M | 21.7M | 23.6M | 25.5M | 9.5M | 9.7M | 6.6M | 7.6M | 15.0M | 13.4M | 7.8M | 7.0M |
| 營業利益 | 42.9M+120% | 63.7M+216% | 59.1M-1899% | 51.3M-436% | 19.5M-217% | 20.1M-228% | −3.3M-69% | −15.3M+30% | −16.7M | −15.7M | −10.5M | −11.8M |
| 營業利益率 | 42.1% | 50.0% | 46.0% | 49.2% | 49.2% | 51.5% | -28.7% | -1,898.1% | – | – | – | – |
| 稅後淨利 | 26.0M+31% | 38.6M+87% | 14.0M-605% | 109M-867% | 19.8M-237% | 20.6M-240% | −2.8M-72% | −14.2M+26% | −14.5M | −14.8M | −9.7M | −11.3M |
| 淨利率 | 25.5% | 30.3% | 10.9% | 104.1% | 49.9% | 52.8% | -24.2% | -1,755.5% | – | – | – | – |
| 稀釋 EPS | 0.29+4% | 0.43+43% | 0.20-500% | 1.26-604% | 0.28-212% | 0.30-220% | -0.05-71% | -0.250% | -0.25 | -0.25 | -0.17 | -0.25 |
| 稀釋股數 | 92.5M | 93.0M | 80.3K | 86.2M | 71.9M | 69.0M | 58.8M | 57.6M | 57.5M | 50.9M | 56.6M | 45.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 257M | 178M | 145M | 48.5M | 159M | 66.3M | 35.3M | 28.5M | 35.2M | 43.6M | 53.3M | 19.7M |
| 應收帳款 | 161M | 155M | 171M | 159M | 42.9M | 54.6M | 17.4M | 206K | – | – | – | – |
| 存貨 | 38.6M | 30.7M | 29.7M | 28.9M | 9.6M | 7.5M | 6.6M | 4.0M | 2.3M | 2.1M | – | – |
| 總資產 | 904M | 816M | 826M | 751M | 253M | 150M | 77.6M | 57.7M | 68.0M | 82.1M | 91.4M | 57.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 443M | 379M | 421M | 377M | 32.0M | 34.7M | 18.9M | 11.5M | 10.0M | 11.9M | 8.2M | 8.0M |
| 股東權益 | 461M | 437M | 405M | 374M | 221M | 115M | 58.7M | 46.2M | 58.0M | 70.1M | 83.2M | 49.1M |
| 負債比 | 49.0% | 46.4% | 50.9% | 50.2% | 12.7% | 23.2% | 24.3% | 20.0% | 14.7% | 14.5% | 9.0% | 14.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 42.4M+115% | – | – | – | 19.7M | – | – | −17.3M | – | – | – |
| 資本支出 | – | 729K | – | – | – | 10K | – | – | 61K | – | – | – |
| 自由現金流 | – | 41.7M+111% | – | – | – | 19.7M | – | – | −17.4M | – | – | – |
| 折舊攤銷 | – | 10.5M | – | – | – | 162K | – | – | – | – | – | – |
| 買回庫藏股 | – | 11.1M | – | – | – | 0.00 | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 32.7% | – | – | – | 50.5% | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 312M
| Defen Cath | 259M | 83.0% | +495.4% |
|---|---|---|---|
| Melinta Portfolio | 45.5M | 14.6% | – |
| Contract Revenue | 7.4M | 2.4% | – |
| 產品 小計 | 304M | 97.6% | +600.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 312M | +617.0% | 163M | 52.3% | 2.04 | 173M |
| FY2024 | 43.5M | – | −17.9M | -41.2% | -0.30 | −50.7M |
| FY2023 | – | – | −46.3M | –% | -0.91 | −38.7M |
| FY2022 | 65K | -65.7% | −29.7M | -45,409.9% | -0.74 | −24.6M |
| FY2021 | 191K | -20.2% | −28.2M | -14,774.7% | -0.75 | −22.6M |
| FY2020 | 239K | -15.5% | −22.0M | -9,207.7% | -0.77 | −22.1M |
| FY2019 | 283K | -34.1% | −16.4M | -5,801.3% | -1.80 | −15.1M |
| FY2018 | 430K | – | −26.8M | -6,242.4% | -1.51 | −23.7M |